Monkeypox: a dermatologist perspective.

Monkeypox (MPX) is a human zoonotic disease due to Monkeypox virus. Morbidity and mortality are lower than in other Orthopox virus diseases, in particular smallpox. MPX is an endemic disease of Western and Central Africa. However, a multi-country outbreak is currently taking place in many non-endemic countries. The clinical and epidemiological characteristics of this epidemic appear peculiar, with significant differences compared to those of the endemic areas. In particular, it predominantly affects males having sex with males, and the route of sexual transmission appears to be particularly frequent. This has led to considerable media interest and concern among the population. Dermatologists are likely to be consulted frequently during the outbreak, especially for the differential diagnosis. Indeed, although MPX can affect various organs, the skin is constantly involved. Since the skin rash have different stages of development, MPX should be differentiate from several, common skin diseases, also because the systemic symptoms can be variable and of different severity. Therefore, dermatologists must be aware of the clinical characteristics of the disease and its management.

[1]  David H. Philpott,et al.  Epidemiologic and Clinical Characteristics of Monkeypox Cases - United States, May 17-July 22, 2022. , 2022, MMWR. Morbidity and mortality weekly report.

[2]  D. Sobral,et al.  Phylogenomic characterization and signs of microevolution in the 2022 multi-country outbreak of monkeypox virus , 2022, Nature Medicine.

[3]  A. Chughtai,et al.  Reemergence of Human Monkeypox and Declining Population Immunity in the Context of Urbanization, Nigeria, 2017–2020 , 2021, Emerging infectious diseases.

[4]  U. Moens,et al.  Monkeypox Virus in Nigeria: Infection Biology, Epidemiology, and Evolution , 2020, Viruses.

[5]  M. Koopmans,et al.  Human Monkeypox , 2019, Infectious Disease Clinics of North America.

[6]  C. Ihekweazu,et al.  The 2017 human monkeypox outbreak in Nigeria—Report of outbreak experience and response in the Niger Delta University Teaching Hospital, Bayelsa State, Nigeria , 2019, PloS one.

[7]  Y. Nakazawa,et al.  Epidemiologic and Ecologic Investigations of Monkeypox, Likouala Department, Republic of the Congo, 2017 , 2019, Emerging infectious diseases.

[8]  Nicole A. Hoff,et al.  Varicella Coinfection in Patients with Active Monkeypox in the Democratic Republic of the Congo , 2017, EcoHealth.

[9]  M. Bentahir,et al.  Simple Technique for in Field Samples Collection in the Cases of Skin Rash Illness and Subsequent PCR Detection of Orthopoxviruses and Varicella Zoster Virus , 2014, PloS one.

[10]  I. Bayer-Garner,et al.  Monkeypox virus: histologic, immunohistochemical and electron‐microscopic findings , 2005, Journal of cutaneous pathology.

[11]  P. Leggat,et al.  Human Monkeypox: Current State of Knowledge and Implications for the Future , 2016, Tropical medicine and infectious disease.

[12]  R. Buller,et al.  Human monkeypox: an emerging zoonotic disease. , 2007, Future microbiology.